---
schema_version: "secwatch.filing_event.v1"
accession: "0001655759-24-000091"
form_type: "8-K"
ticker: "ARVN"
cik: "0001655759"
company_name: "ARVINAS, INC."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:07:18.164523+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Arvinas appoints Ian Taylor as President of R&D, Angela Cacace as CSO

## Summary
- Ian Taylor, Ph.D., formerly CSO, becomes President of R&D effective June 15, 2024.
- Angela Cacace, Ph.D., formerly SVP Neuroscience and Platform Biology, appointed CSO.
- Cacace joined Arvinas in 2018 and will drive early research pipeline.
- Taylor will also chair the company's scientific advisory board.

## SEC filing metadata
- accession: 0001655759-24-000091
- form_type: 8-K
- ticker: ARVN
- cik: 0001655759
- company_name: ARVINAS, INC.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1655759/000165575924000091/0001655759-24-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1655759/000165575924000091/arvn-20240615.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001655759-24-000091
- JSON: https://secwatch.observer/filing/0001655759-24-000091.json
- Plain text: https://secwatch.observer/filing/0001655759-24-000091.txt

## Key facts
- Executive change
  Angela Cacace was appointed as Chief Scientific Officer at ARVINAS, INC..
  - Action: appointed
  - Role: Chief Scientific Officer
  source text: and the appointment of Angela Cacace, Ph.D. as the Company’s chief scientific officer (“CSO”), a role previously held by Dr. Taylor.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1655759/000165575924000091/0001655759-24-000091-index.htm
- Executive change
  Ian Taylor was appointed as President of Research and Development at ARVINAS, INC..
  - Action: appointed
  - Role: President of Research and Development
  source text: On June 17, 2024, Arvinas, Inc., a Delaware corporation (the “Company”), announced the appointment of Ian Taylor, Ph.D. as the Company’s president of research and development (“R&D”), a role previously held by John Houston, Ph.D.,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1655759/000165575924000091/0001655759-24-000091-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.